Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Acquisitions (2021 - 2023)

Historic Acquisitions for Oncology Institute (TOI) over the last 3 years, with Q4 2023 value amounting to $156000.0.

  • Oncology Institute's Acquisitions fell 6680.85% to $156000.0 in Q4 2023 from the same period last year, while for Dec 2024 it was $156000.0, marking a year-over-year increase of 18342.25%. This contributed to the annual value of $4.5 million for FY2023, which is 4804.71% down from last year.
  • Oncology Institute's Acquisitions amounted to $156000.0 in Q4 2023, which was down 6680.85% from $470000.0 recorded in Q4 2022.
  • Oncology Institute's 5-year Acquisitions high stood at $8.9 million for Q2 2022, and its period low was -$813000.0 during Q3 2022.
  • In the last 3 years, Oncology Institute's Acquisitions had a median value of $648500.0 in 2021 and averaged $3.0 million.
  • As far as peak fluctuations go, Oncology Institute's Acquisitions tumbled by 9432.37% in 2022, and later crashed by 6680.85% in 2023.
  • Oncology Institute's Acquisitions (Quarter) stood at $8.3 million in 2021, then plummeted by 94.32% to $470000.0 in 2022, then crashed by 66.81% to $156000.0 in 2023.
  • Its last three reported values are $156000.0 in Q4 2023, $470000.0 for Q4 2022, and -$813000.0 during Q3 2022.